Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Iroxanadine (BRX-005) is a Novel small molecule MAPK p38 inhibitor that induces phosphorylation of p38 SAPK and induces concentration-dependent relaxation in guinea pig pulmonary artery preparations precontracted with phenylephrine.CAS 번호13480-84-5
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 33,500 | |||
5 mg | 在庫あり | ¥ 80,500 | |||
10 mg | 在庫あり | ¥ 122,000 | |||
25 mg | 在庫あり | ¥ 197,500 | |||
50 mg | 在庫あり | ¥ 271,000 | |||
100 mg | 在庫あり | ¥ 365,000 | |||
500 mg | 在庫あり | ¥ 732,500 |
説明 | Iroxanadine (BRX-005) is a Novel small molecule MAPK p38 inhibitor that induces phosphorylation of p38 SAPK and induces concentration-dependent relaxation in guinea pig pulmonary artery preparations precontracted with phenylephrine.CAS 번호13480-84-5 |
別名 | BRX005, BRX-235, BRX-005, BRX235, BRX 005, BRX 235 |
分子量 | 260.33 |
分子式 | C14H20N4O |
CAS No. | 203805-20-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (172.86 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Iroxanadine 203805-20-3 MAPK p38 MAPK BRX005 BRX-235 BRX-005 BRX235 BRX 005 BRX 235 Inhibitor inhibitor inhibit